Switching from Nifedipine to Amlodipine for Angina and Hypertension

Rationale for Switching from Nifedipine to Amlodipine

• Immediate-release nifedipine is specifically contraindicated in patients with acute coronary syndromes and should not be administered without beta-blocker therapy, as recommended by the American Heart Association 1, 2

Additional Management Considerations

• The American Heart Association recommends that if the patient is not already on a beta-blocker, consider adding one for optimal angina management, as guidelines recommend beta-blockers as first-line therapy for patients with angina and prior MI 3, 4
• Long-acting dihydropyridine calcium channel blockers, like amlodipine, are preferred for use in combination with beta-blockers to avoid excessive bradycardia or heart block, according to the American College of Cardiology 5
• Amlodipine has been shown to cause common side effects, including headache and peripheral edema, as reported by the Journal of the American College of Cardiology 6

Important Cautions

• The American Heart Association recommends that calcium channel blockers, such as amlodipine, should be used with caution in patients with left ventricular dysfunction or heart failure, and beta-blockers and ACE inhibitors would be preferred agents 1, 5
• Amlodipine is a safer choice than immediate-release nifedipine, which can cause reflex sympathetic activation and worsen myocardial ischemia, as stated by the American Heart Association 5
• For patients with vasospastic angina, amlodipine's once-daily dosing offers better compliance, according to the American Heart Association 3